Abstract
Parkinson's disease (PD) is the most common neurodegenerative movement disorder, characterized clinically by resting tremor, bradykinesia, postural instability and rigidity. The prevalence of PD is approximately 2% of the population over 65 years of age and 1.7 million PD patients (age > or = 55 years) live in China. Recently, a common LRRK2 variant Gly2385Arg was reported in ethnic Chinese PD population in Taiwan. We analyzed the frequency of this variant in our independent PD case-control population of Han Chinese from Taiwan. 305 patients and 176 genetically unrelated healthy controls were examined by neurologists and the diagnosis of PD was based on the published criteria. The region of interest was amplified with standard polymerase chain reaction (PCR). PCR fragments then were directly sequenced in both forward and reverse directions. Differences in genotype frequencies between groups were assessed by the X2 test, while X2 analysis was used to test for the Hardy-Weinberg equilibrium. Of the 305 patients screened we identified 27 (9%) with heterozygous G2385R variant. This mutation was only found in 1 (0.5%) in our healthy control samples (odds ratio = 16.99, 95% CI: 2.29 to 126.21, p = 0.0002). Sequencing of the entire open reading frame of LRRK2 in G2385R carriers revealed no other variants. These data suggest that the G2385R variant contributes significantly to the etiology of PD in ethnic Han Chinese individuals. With consideration of the enormous and expanding aging Chinese population in mainland China and in Taiwan, this variant is probably the most common known genetic factor for PD worldwide.
MeSH Terms
Adult
Aged
Aged, 80 and over
Asians/genetics,statistics & numerical data
DNA Mutational Analysis
Female
Genetic Predisposition to Disease/epidemiology,genetics
Genetic Testing/methods
Humans
Leucine-Rich Repeat Serine-Threonine Protein Kinase-2
Male
Middle Aged
Parkinson Disease/ethnology,genetics
Polymorphism, Single Nucleotide/genetics
Prevalence
Protein Serine-Threonine Kinases/genetics
Risk Assessment/methods
Risk Factors
Taiwan/ethnology
Chemicals
LRRK2 protein, human
Leucine-Rich Repeat Serine-Threonine Protein Kinase-2
Protein Serine-Threonine Kinases
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Fung Hon-Chung
Department of Neurology, Chang Gung Memorial Hospital and College of Medicine, Chang Gung University, 199 Tung-Hwa North Road, Taipei, 10591, Taiwan. fungp@mail.nih.gov <fungp@mail.nih.gov>
Chen Chiung-Mei
Hardy John
Singleton Andrew B
Wu Yih-Ru
References (13)
13 references, click to expand
-
LRRK2 mutations in Parkinson disease.
Neurology. 2005 Sep 13;65(5):738-40
PMID: 16157908
-
Prevalence of Parkinson's disease in China.
Lancet Neurol. 2005 Jun;4(6):328-9
PMID: 15907734
-
Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology.
Neuron. 2004 Nov 18;44(4):601-7
PMID: 15541309
-
Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease.
Neuron. 2004 Nov 18;44(4):595-600
PMID: 15541308
-
Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.
J Neurol Neurosurg Psychiatry. 1992 Mar;55(3):181-4
PMID: 1564476
-
Prevalence of Parkinson's disease and related disorders in the elderly population of greater Beijing, China.
Mov Disord. 2003 Jul;18(7):764-72
PMID: 12815655
-
The LRRK2 Gly2385Arg variant is associated with Parkinson's disease: genetic and functional evidence.
Hum Genet. 2007 Feb;120(6):857-63
PMID: 17019612
-
A common missense variant in the LRRK2 gene, Gly2385Arg, associated with Parkinson's disease risk in Taiwan.
Neurogenetics. 2006 Jul;7(3):133-8
PMID: 16633828
-
Lack of G2019S LRRK2 mutation in a cohort of Taiwanese with sporadic Parkinson's disease.
Mov Disord. 2006 Jun;21(6):880-1
PMID: 16511860
-
Lrrk2 pathogenic substitutions in Parkinson's disease.
Neurogenetics. 2005 Dec;6(4):171-7
PMID: 16172858
-
How genetics research in Parkinson's disease is enhancing understanding of the common idiopathic forms of the disease.
Curr Opin Neurol. 2005 Dec;18(6):706-11
PMID: 16280683
-
The dardarin G 2019 S mutation is a common cause of Parkinson's disease but not other neurodegenerative diseases.
Neurosci Lett. 2005 Dec 9;389(3):137-9
PMID: 16102903
-
Kinase activity is required for the toxic effects of mutant LRRK2/dardarin.
Neurobiol Dis. 2006 Aug;23(2):329-41
PMID: 16750377